Transcript (.pdf)

For more information on this session, including access to speaker presentations, please see the conference Programme-at-a-Glance.

The Global Fund to fight AIDS, TB and Malaria was created in 2002 when the world realized it was failing to respond adequately to the AIDS epidemic, TB and malaria. Since then the Global Fund Board has approved proposals totalling US$ 19.2 billion, and disbursed US$ 10 billion. It now provides 63 percent of all external financing in developing countries for TB, 57 percent for malaria, and about 20 percent for HIV, including antiretroviral therapy (ART) to 2.5 million people. This session will look at the evidence of the impact that the Global Fund is having on preventing new infections and reducing mortality. In particular it will focus on its role in scaling up more effective responses to HIV, and within that the importance of Global Fund financing of human rights based programming and advocacy. The panel will discuss the future role that the Global Fund needs to play in the AIDS response to attain universal access, and what might be achieved through a fully funded replenishment in October 2010.

Presentations in This Session:

Introduction

Global Fund Achievements and Future Possibilities
Michel Kazatchkine (Switzerland)

Role of the Global Fund in Supporting Ruman Rights-Based Approaches to HIV
Joanne Csete (United States)

Panel Discussion

Raminta Stuikyte (Lithuania)
Michel Kazatchkine (Switzerland)
Joanne Csete (United States)

Questions and Answers

Closing Remarks

The Global Fund: Proving Impact, Promoting Rights (.mp3)